Search
for
Sort by
Research 91–120 of 1000+
- The risk of dementia with the use of 5 alpha reductase inhibitors
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Algorithmic approach to the treatment of frontal fibrosing alopecia: A systematic review
- Common urologic diseases in older men and their treatment: how they impact fertility
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Treatment of Alopecia with New Approaches: An Updated Review
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Impact of finasteride and dutasteride in beard thickness in men with androgenetic alopecia: a 453-patient retrospective trial
- Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
- Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database review.
- Editor’s picks January 2021
- MP09-16 5-ALPHA REDUCTASE INHIBITORS FOR MALE LOWER URINARY TRACT SYMPTOMS: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS
- 5α‐Reductase Inhibitors